The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and Outcome
Abstract
To determine risk factors, frequency, time patterns, and outcome of ganciclovir-related neutropenia in allogeneic marrow transplant recipients, 278 consecutive patients receiving ganciclovir from engraftment until day 100 were studied. In this cohort, 159 patients (57%) had absolute neutrophil counts (ANC) less than 1,500/μL, 112 (41%) had an ANC less than 1,000/μL, 87 (31%) less than 750/μL, and 56 (21%) less than 500/μL for at least 2 consecutive days. Statistically significant risk factors for neutropenia in a Cox model were low marrow cellularity between day 21 and 28 (relative risk [RR] 2.4, P = .0002), hyperbilirubinemia ≥6 mg/dL during the first 20 days (RR 2.5, P = .0001), and elevation of serum creatinine ≥2 mg/dL after day 21 after transplant (RR 2.1, P = .001). Restriction to factors present at engraftment resulted in a similar model with low marrow cellularity, hyperbilirubinemia ≥6 mg/dL, and elevated serum creatinine as significant risk factors. Patients with no risk factor had an incidence of neutropenia of 21%, an incidence of 31% for one risk factor, and of 57% for two or more risk factors (RR 3.8, P = .001). Neutropenia was a negative predictor of overall (RR 2.0, P = .0001) and event-free survival (RR 2.1, P < .0001), and a predictor of relapse (RR 1.7, P = .03) and nonrelapse mortality (RR 2.1, P = .003). Thus, early liver dysfunction, elevated serum creatinine, and low marrow cellularity are risk factors for ganciclovir-related neutropenia. Neutropenia in ganciclovir recipients after marrow transplantation is an independent risk factor for mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
Cited by
Marr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493
Self-citationQuantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
Boeckh, M., & Boivin, G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.533 · Cited by 438
Self-citationCytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman, P., Hakki, M., & Boeckh, M. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.011 · Cited by 423
Self-citationNichols, W. G., Corey, L., Gooley, T., Davis, C., & Boeckh, M. (2002) · The Journal of Infectious Diseases · doi:10.1086/338624 · Cited by 422
Self-citationBroers, A. E. C., van der Holt, R., van Esser, J. W. J., Gratama, J.-W., Henzen-Logmans, S., Kuenen-Boumeester, V., Löwenberg, B., & Cornelissen, J. J. (2000) · Blood · doi:10.1182/blood.v95.7.2240 · Cited by 348
Metadata
- Authors
- Salzberger, B., Bowden, R. A., Hackman, R. C., Davis, C., & Boeckh, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-09-15
- Volume
- 90
- Issue
- 6
- Pages
- 2502-2508
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1533537097
- Cited by
- 227
- References
- 1
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and Outcome. https://app.cochat.ai/papers/10.1182/blood.v90.6.2502
- The paper
- Salzberger, B., Bowden, R. A., Hackman, R. C., Davis, C., & Boeckh, M. (1997). Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and Outcome. Blood. https://doi.org/10.1182/blood.v90.6.2502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.